Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Randomized Controlled Trial of Intratumoral Lidocaine Injection Before Transoral Robotic Surgery (TORS) and Neck Dissection for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

NCT06747390 is registered in ClinicalTrials.gov with Ryan Carey as lead sponsor.

NCT NCT06747390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06747390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Randomized Controlled Trial of Intratumoral Lidocaine Injection Before Transoral Robotic Surgery (TORS) and Neck Dissection for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Lead sponsor
Ryan Carey
Phase
Phase 1
Overall status
Recruiting
Start date
April 23, 2025
Completion date
November 1, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus, oropharyngeal cancer, oropharyngeal squamous cell carcinoma (opscca), squamous cell carcinoma